Ledger.Open graph →
SEC Form D · filed November 15, 2022

Virocell Biologics Ltd

Offering
$2.3M
Sold
$993K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

John W. Hadden Ii · New York, NYExec · DirectorPeter E. Priestley · Dublin, IrelandDirectorFarzin E. Farzaneh · London, United KingdomExec · DirectorTodd C. Davis · Jupiter, FLDirectorJ D. Enloe Jr · San Diego, CADirectorPeter E. Priestley · Dublin, IrelandDirectorFarzin E. Farzaneh · London, United KingdomExec · DirectorTodd C. Davis · Jupiter, FLDirectorJohn W. Hadden Ii · New York, NYExec · DirectorJ D. Enloe Jr · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗